 insulin-independent mechanism intrathecal morphine-induced hypoglycemia mice mediation central adrenergic pathway Studies mechanism hypoglycemia i.t administration morphine micrograms unanesthetized mice assessment effects i.t morphine levels immunoreactive insulin glucagon body temperature effects i.p pretreatment antagonists cholinergic beta adrenergic adrenergic adrenergic serotonergic opioid receptors Serum levels insulin min i.t morphine glucagon levels time points Rectal temperature mice saline morphine significant difference groups time Atropine mg/kg propranolol mg/kg prazosin mg/kg methysergide mg/kg morphine-induced hypoglycemia Naloxone mg/kg i.t morphine Mecamylamine mg/kg moderate hypoglycemia control mice additive i.t morphine Yohimbine mg/kg i.p moderate hypoglycemia control mice dose-related antagonism i.t morphine active antagonist pyrimidin hydrochloride mg/kg i.p selective antagonist -N- oxospiro ethyl hydrochloride mg/kg i.p dose-related antagonism i.t morphine i.t coadministration yohimbine micrograms micrograms morphine antagonism